Search

everythinglearnresearchcommunity

for

Search:↓

A patient with Ivemark syndrome developed mixed type vitiligo after a hepatitis C infection, showing different treatment responses and immune cell involvement in the skin.

Hepatitis C treatment may cause frontal fibrosing alopecia.

Compound 1 showed promising anticancer activity.

A new method effectively predicts estrogen-related health effects for early screening.

Finasteride improves immune response and reduces organ damage after trauma hemorrhage in mice.

Semecarpus anacardium leaf extracts may offer safe, effective cancer treatment alternatives.

Using protein degradation to fight cancer drug resistance shows promise but needs more precise targeting and fewer side effects.

Saw palmetto supplements may reduce prostate cancer cell growth without being toxic.

Ginsenoside compound K shows promise for treating metabolic diseases like diabetes and obesity.

A kidney transplant and immunosuppressive treatment stopped the skin disease in a patient.

Researchers found new potential but less potent rat enzyme inhibitors using a 3D model.

Some cancer and immune system drugs can cause serious side effects, including heart, lung, nerve, and organ damage, which need careful monitoring and management.

Certain hormones can reduce skin oil and hair growth, potentially helping treat acne and excessive hair in women.

Herbal remedies like ginseng and green tea may help regenerate hair follicles damaged by pesticides.

Certain compounds can protect hair cells from aging and promote growth.

Psychotropic drugs can interact with natural products, affecting their effectiveness and safety.

Letrozole may help prevent seizures by reducing certain hormone levels.

Antiandrogens can treat acne, hirsutism, and seborrhea by reducing sebum production and androgen action.

The lotion with equol, dihomo-γ-linolenic acid, and propionyl-l-carnitine was effective in reducing hair loss in men and women.

Proteoglycans are vital for tissue growth and healing, with potential as treatment targets.

Targeting protein S-palmitoylation could lead to new skin disease treatments.

Nanoparticles with specific drugs can help regrow hair in alopecia areata.

Troglitazone increases subcutaneous fat in lipodystrophy patients.

The inhibitor DPP can promote hair growth.

The HDDPiW-jSB solution may prevent hair loss caused by docetaxel in rats when applied regularly.

Three compounds were found to inhibit a prostate disease-related enzyme and reduce prostate size more effectively than the current treatment, suggesting they could be used for treating benign prostatic hyperplasia.

Reconstructed skin models are useful for studying how skin processes certain chemicals.

Myoblast transplantation shows promise for treating various muscle and heart conditions.

Chemotherapy-induced hair loss is a major concern, but various treatments show promise in preventing and reversing it.

Dutasteride may protect brain cells in early Parkinson's, while progesterone helps neuron recovery.